F80
Conditions
Interventions
Group 1: Children aged 3
0-6
11 years at study initiation, with a diagnosed SES, will receive 20 speech and language therapies. The children are divided into 4 groups with different treatment settings: 1) ambulant extensive speec
Group 2: 2) intensive stationary speech therapy
3) intensive ambulant small group therapy
4) extensive tele-videotherapy.Each group includes a waiting-control group and a direct treatment group. Children will receive EEGs from each of the four treatment setting groups. There are a total o
Group 4: 4) extensive tele-videotherapy.Each group includes a waiting-control group and a direct treatment group. Children will receive EEGs from each of the four treatment setting groups. There are
Sponsors
Klinik für Phoniatrie und Pädaudiologie des Universitätsklinikums Münster
Eligibility
Sex/Gender
All
Age
36 Months to 95 Months
Inclusion criteria
Inclusion criteria: Study arm 1-4: The child - uses German as first language - shows an IQ in a developmental diagnostic =85 - has a peripheral normakusis bds. - A moderate to severe speech language development disorder Study arm 5: The child - uses German or another first language - has a peripheral normakusis bds. - has just started a logopedic treatment due to speech development problems (max. since 3 months, max. 10 sessions received) or a prescription for such a treatment is available and the start of treatment is still to come
Exclusion criteria
Exclusion criteria: Study arm 1-4: - motor, cognitive, anatomical or sensory disorders that may be associated with language deficits - Fluency disorders - profound developmental disorder (e.g. autism or mental disorder) - received speech therapy in the last 3 months - childhood apraxia of speech (CAS) Study arm 5: - motor, cognitive, anatomical or sensory disorders, which may be associated with language deficits - Fluency disorders - profound developmental disorder (e.g. autism or mental disorder) - childhood apraxia of speech (CAS)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Study arm 1-4: Speech language development status at time point T2 (12 months after therapy start) Study arm 5: retrospectively extrapolated speech development status at the time of the speech language diagnosis that led to the therapy indication | — |
Secondary
| Measure | Time frame |
|---|---|
| Study arm 1-4: Scores of the "Intelligibilty in Context Scale" and one questionnaire each on health-related quality of life for children (Giessen Complaint Form for Children and Adolescents GBB-KJ) and their parents (Giessen Complaint Form GBB-24) at time T2 Study arm 5: average test scores of German and non-German language tests for the individual linguistic levels semantics/lexicon and syntax/morphology and phonology and for the phonological working memory | — |
Countries
Germany
Contacts
Public ContactKatrin Neumann
Klinik für Phoniatrie und Pädaudiologie des Universitätsklinikums Münster
Outcome results
None listed